Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Opus Genetics (IRD)
NASDAQ:IRD
Holding IRD?
Track your performance easily
See the Price Targets and Ratings of:
IRD Analyst Ratings
Moderate Buy
2 Buy
0 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
IRD Stock 12 Month Forecast
Average Price Target
$9.50
▲(771.56% Upside)
| Highest Price Target$10.00 | Average Price Target$9.50 | Lowest Price Target$9.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Canaccord Genuity
Reiterated
11/12/24
JonesTrading
Reiterated
11/12/24
H.C. Wainwright
$18
Buy
1551.38%
Upside
Reiterated
08/14/24
Based on adjusting our commercialization estimates from 2025 to 2026 in our model for partnered asset phentolamine (ophthalmic solution 0.75%), and APX3330, respectively, our price target has been reduced to $18 from $20. We reiterate our Buy rating. Our price target of $18 is based on an equally-weighted composite of: (a) $20.64 per share, as a 25x multiple of taxed and diluted 2034 EPS of $2.85 discounted back to and (b) an NPV discounted cash flow between 2024-2034 of $15.21 per share, with a discount rate of 13% and growth rate of 1%.
Alliance Global Partners
$24→$20
Buy
1734.86%
Upside
Reiterated
03/20/24
Ocuphire Pharma price target lowered to $20 from $24 at Alliance GlobalOcuphire Pharma price target lowered to $20 from $24 at Alliance Global
Best Analysts Covering Opus Genetics
Which Analyst Should I Follow If I Want to Buy IRD and Sell After:
1 Month
xxx
Success Rate
7/18 ratings generated profit
Average Return
-1.42%
reiterated a xxx
rating 4 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 38.89% of your transactions generating a profit, with an average return of -1.42% per trade.
3 Months
xxx
Success Rate
7/18 ratings generated profit
Average Return
+1.37%
reiterated a xxx
rating 4 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 38.89% of your transactions generating a profit, with an average return of +1.37% per trade.
1 Year
Success Rate
6/18 ratings generated profit
Average Return
-4.69%
reiterated a buy rating 4 months ago
Copying Matthew Caufield's trades and holding each position for 1 Year would result in 33.33% of your transactions generating a profit, with an average return of -4.69% per trade.
2 Years
xxx
Success Rate
1/13 ratings generated profit
Average Return
-35.13%
reiterated a xxx
rating 15 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 7.69% of your transactions generating a profit, with an average return of -35.13% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
IRD Analyst Recommendation Trends
Rating
May 24
Aug 24
Sep 24
Oct 24
Nov 24
Strong Buy
6
6
6
5
4
Buy
1
1
1
0
0
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
7
7
7
5
4
Each month's total comprises the sum of three months' worth of ratings.
IRD Financial Forecast
IRD Stock Forecast FAQ
What is IRD’s average 12-month price target, according to analysts?
Based on analyst ratings, Opus Genetics’s 12-month average price target is $9.50.
What is IRD’s upside potential, based on the analysts’ average price target?
Opus Genetics has 771.56% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is IRD a Buy, Sell or Hold?
Opus Genetics has a consensus rating of Moderate Buy which is based on 2 buy ratings, 0 hold ratings and 0 sell ratings.
What is Opus Genetics’s price target?
The average price target for Opus Genetics is $9.50. This is based on 2 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $10.00 ,the lowest forecast is $9.00. The average price target represents 771.56% Increase from the current price of $1.09.
The highest analyst price target is $10.00 ,the lowest forecast is $9.00. The average price target represents 771.56% Increase from the current price of $1.09.
What do analysts say about Opus Genetics?
Opus Genetics’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 2 Wall Streets Analysts.
How can I buy shares of IRD?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.